Heidi L. Wagner's most recent trade in Wave Life Sciences Ltd. was a trade of 14,000 Share Option (right to buy) done . Disclosure was reported to the exchange on Dec. 8, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Wave Life Sciences Ltd | Heidi L. Wagner | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Dec 2025 | 14,000 | 7,000 | - | - | Share Option (right to buy) | |
| Wave Life Sciences Ltd | Heidi L. Wagner | Director | Sale of securities on an exchange or to another person at price $ 14.00 per share. | 08 Dec 2025 | 7,000 | 44,930 (0%) | 0% | 14 | 98,000 | Ordinary Shares |
| Wave Life Sciences Ltd | Heidi L. Wagner | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.97 per share. | 08 Dec 2025 | 7,000 | 51,930 (0%) | 0% | 6.0 | 41,790 | Ordinary Shares |
| Wave Life Sciences Ltd | Heidi L. Wagner | Director | Sale of securities on an exchange or to another person at price $ 13.00 per share. | 08 Dec 2025 | 7,000 | 44,930 (0%) | 0% | 13 | 91,000 | Ordinary Shares |
| Wave Life Sciences Ltd | Heidi L. Wagner | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.97 per share. | 08 Dec 2025 | 7,000 | 51,930 (0%) | 0% | 6.0 | 41,790 | Ordinary Shares |
| Wave Life Sciences Ltd | Heidi L. Wagner | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Aug 2025 | 76,200 | 76,200 | - | - | Share Option (right to buy) | |
| Wave Life Sciences Ltd | Heidi L. Wagner | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Aug 2025 | 12,700 | 44,930 (0%) | 0% | 0 | Ordinary Shares | |
| Wave Life Sciences Ltd | Heidi L. Wagner | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Aug 2024 | 64,460 | 64,460 | - | - | Share Option (right to buy) | |
| Wave Life Sciences Ltd | Heidi L. Wagner | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Aug 2024 | 32,230 | 32,230 (0%) | 0% | 0 | Ordinary Shares | |
| Wave Life Sciences Ltd | Heidi L. Wagner | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Aug 2023 | 45,000 | 45,000 | - | - | Share Option (right to buy) | |
| Wave Life Sciences Ltd | Heidi L. Wagner | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Aug 2022 | 21,000 | 21,000 | - | - | Share Option (right to buy) | |
| Wave Life Sciences Ltd | Heidi L. Wagner | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Aug 2021 | 21,000 | 21,000 | - | - | Share Option (right to buy) |